Cardioprotection conferred by sitagliptin is associated with reduced cardiac angiotensin II/Angiotensin-(1-7) balance in experimental chronic kidney disease
Treatment Goals: Patients using the medication for diabetes may have a different testing schedule than those using it solely for weight loss
Obes Rev 22:e13200 Morais JBS, Dias TMDS, Cardoso BEP, de Paiva SM, Sousa TGV, Arajo DSC, Marreiro DDN (2022) Adipose tissue dysfunction: impact on metabolic changes
Videos should show: the procedure carried out and, if available, photographic documentation of the pre- and post-treatment situation and the long-term result
Its efficacy has been demonstrated through significant improvements in liver function, reduction of inflammatory cytokines, and attenuation of hepatic steatosis
doi: 10.3389/fimmu.2022.835879 9 SullivanMAForbesJM